Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
J Hypertens
    July 2025

  1. Hypertension determinants among Ghanaians differ according to location of residence: RODAM study: Erratum.
    J Hypertens. 2025;43:1266.
    >> Share

  2. OBEIDAT M
    Editorial commentary on: "assessing the relationship between short-term blood pressure variability and glycation profile in young and middle-aged nondiabetic hypertensive individuals".
    J Hypertens. 2025;43:1146-1147.
    >> Share

  3. LOH HH, Azizan EA, Sukor N
    Connecting the dots: renin-angiotensin-aldosterone system, vitamin D, and hypertension.
    J Hypertens. 2025;43:1136-1145.
    >> Share

  4. RIAR SK, Gillespie S, South AM
    Within-visit blood pressure variability in children and adolescents in the National Health and Nutrition Examination Survey (2013-2020).
    J Hypertens. 2025;43:1158-1168.
    >> Share

  5. MALM EHJ, Petersen AW, Hadad R, Haugaard SB, et al
    Admission blood pressure and blood pressure variability in medical emergency predicts 3-month mortality and readmission.
    J Hypertens. 2025;43:1198-1204.
    >> Share

  6. O'HAGAN ET, Marschner SL, Quintans D, Hillis GS, et al
    Sex differences in blood pressure lowering of initial treatment with ultra-low dose combination therapy versus monotherapy. A secondary analysis of QUARTET.
    J Hypertens. 2025;43:1256-1260.
    >> Share

    June 2025
  7. DE LA SIERRA A, Ruilope LM, Staplin N, Stergiou GS, et al
    Mortality risks in different subtypes of white-coat hypertension: implications for the diagnosis of white-coat hypertension.
    J Hypertens. 2025 Jun 10. doi: 10.1097/HJH.0000000000004076.
    >> Share

  8. ZHANG W, Yan J, Zhang J, Ge Q, et al
    Blood pressure-lowering efficacy of Sacubitril/Allisartan versus Olmesartan in Chinese hypertensive patients with a nondipping blood pressure pattern.
    J Hypertens. 2025 Jun 6. doi: 10.1097/HJH.0000000000004065.
    >> Share

  9. DIAZ-AROCUTIPA C, Salguero-Bodes R, Puerto E, Martin-Asenjo R, et al
    Sex disparities in awareness, treatment, and control of hypertension in Peru.
    J Hypertens. 2025 Jun 6. doi: 10.1097/HJH.0000000000004072.
    >> Share

  10. DODULIK J
    Response to Dr Hassan's letter regarding our article Pharmacotherapy of arterial hypertension in patients with psoriasis.
    J Hypertens. 2025;43:1087-1088.
    >> Share

  11. HASSAN IN
    Critical appraisal of antihypertensive therapy in psoriasis: limitations and future directions.
    J Hypertens. 2025;43:1086.
    >> Share

  12. COTTRELL EC
    Commentary on: "Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease".
    J Hypertens. 2025;43:949-950.
    >> Share

  13. GNANENTHIRAN SR, Delgado S, Mirabito Colafella KM, Schlaich MP, et al
    Changing the paradigm of long-term blood pressure control: a systematic review of novel therapies.
    J Hypertens. 2025;43:917-928.
    >> Share

  14. QIAN J, Zhou Z, Zheng Y, Rong S, et al
    Catheter-based ultrasound nerve stimulation and selective renal denervation: a preliminary case series study.
    J Hypertens. 2025;43:1083-1085.
    >> Share

  15. LIP S, Tran TQB, Hanna R, Nichol S, et al
    Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure - LOCHINVAR.
    J Hypertens. 2025;43:1057-1065.
    >> Share

  16. COCA A, Borghi C, Stergiou GS, Ly NF, et al
    Long-term event rates, risk factors, and treatment pattern in 1.4 million individuals qualifying for dual blood pressure lowering therapy.
    J Hypertens. 2025;43:993-1002.
    >> Share

  17. KULKARNI S, Parati G, Bangalore S, Bilo G, et al
    Blood pressure variability: a review.
    J Hypertens. 2025;43:929-938.
    >> Share

  18. PALSMA T, Claassen JAHR, Richard E, De Heus RAA, et al
    Day-to-day blood pressure variability in older persons - optimizing measurement.
    J Hypertens. 2025;43:970-975.
    >> Share

    May 2025
  19. MINARI TP, de Rosso VV, Manzano CF, Humsi MJ, et al
    Correlation of the Mediterranean-Dietary Approaches to Stop Hypertension diet vs. ultra-processed diet with health outcomes in type 2 diabetes and hypertension: new insights from a 12-month interventional study.
    J Hypertens. 2025 May 21. doi: 10.1097/HJH.0000000000004061.
    >> Share

  20. LIN T, Jiang W, Lin Y, Zhang M, et al
    Association between cardiorespiratory fitness and pediatric primary hypertension: a case-control study in China.
    J Hypertens. 2025 May 21. doi: 10.1097/HJH.0000000000004036.
    >> Share

  21. PARATI G, Pengo MF, Avolio A, Azizi M, et al
    Nocturnal blood pressure: pathophysiology, measurement and clinical implications. position paper of the European Society of Hypertension.
    J Hypertens. 2025 May 19. doi: 10.1097/HJH.0000000000004053.
    >> Share

  22. STOUTENBURG EG, Bravo MC, Howard VJ, Judd SE, et al
    Factor IX and incident hypertension in Black and White adults: the REasons for Geographic and Racial Differences in Stroke cohort.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004045.
    >> Share

  23. EDDISON CHUNG HUNG C, Kocherry C, George J
    Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertension.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004055.
    >> Share

  24. WYSZYNSKA J, Luszczki E, Seeman T, Simonetti GD, et al
    Hypertension in children with intellectual disabilities: a population not to be overseen.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004052.
    >> Share

  25. ZHANG L, Liu J
    Spironolactone protects against hypertension-induced renal fibrosis by promoting autophagy and inhibiting the NLRP3 inflammasome.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004020.
    >> Share

  26. SINGAL AM, Howard VJ, Judd SE, Carson AP, et al
    Association between serum adiponectin and risk of incident hypertension: the REGARDS study.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004057.
    >> Share

  27. DEGENAAR A, Kruger R, Jacobs A, Pieters M, et al
    Differential associations between kidney and vascular health biomarkers in young adults stratified by blood pressure status: The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension study.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004051.
    >> Share

  28. JAGADESH G, A R R, Nagarajan S
    Effect of systemic hypertension on retinal layers in patients without retinopathy.
    J Hypertens. 2025 May 6. doi: 10.1097/HJH.0000000000004042.
    >> Share

  29. HU L, Li J, Wang W, Li Y, et al
    Hypertension accelerates the development of a diabetic nephropathy model with more relevant clinical features in Dahl salt-sensitive rat.
    J Hypertens. 2025 May 2. doi: 10.1097/HJH.0000000000004038.
    >> Share

  30. FAVA C, Dal Pont C, Sartorio A, Contro A, et al
    Local release of renin unveils intrarenal arterial fibromuscular dysplasia.
    J Hypertens. 2025;43:909-913.
    >> Share

  31. SEALEY JE, Blumenfeld JD
    Hypothesis: Reactive increases in plasma renin activity attenuate the fall in blood pressure caused by salt depletion and renin-angiotensin system inhibition.
    J Hypertens. 2025;43:739-746.
    >> Share

  32. LEIVA SISNIEGUEZ CE, Olano RD, Stavile RN, Minetto J, et al
    Is the heart rate dipping pattern associated with sleep quality during an ambulatory blood pressure monitoring? A cross-sectional study.
    J Hypertens. 2025;43:790-796.
    >> Share

    April 2025
  33. LI H, Sun R, Li Y, Yue X, et al
    Controversies in hypertension therapy: bedtime dosing or daytime dosing?
    J Hypertens. 2025 Apr 24. doi: 10.1097/HJH.0000000000004035.
    >> Share

  34. NADERI H, Ramirez J, Van Duijvenboden S, Ruiz Pujadas E, et al
    Diagnostic and prognostic value of ECG-predicted hypertension-mediated left ventricular hypertrophy using machine learning.
    J Hypertens. 2025 Apr 24. doi: 10.1097/HJH.0000000000004034.
    >> Share

  35. VAZQUEZ-AGRA N, Barrera-Lopez L, Marques-Afonso AT, Cruces-Sande A, et al
    Assessing the relationship between short-term blood pressure variability and glycation profile in young and middle-aged nondiabetic hypertensive individuals.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004029.
    >> Share

  36. WANG A, Koshiaris C, Archer L, Riley RD, et al
    Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004032.
    >> Share

  37. LIN RT, Gao JW, Yang YC, Chen XW, et al
    Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004037.
    >> Share

  38. JAIN A
    A young woman with severe renovascular hypertension due to essential thrombocytosis: case report and literature review.
    J Hypertens. 2025 Apr 8. doi: 10.1097/HJH.0000000000004031.
    >> Share

  39. RENNA NF, Ramirez EI, Vissani S, Farez BG, et al
    Optimizing hypertension management: the impact of drug class, socioeconomic factors, and simplified regimens on medication adherence. VATAHTA study.
    J Hypertens. 2025 Apr 7. doi: 10.1097/HJH.0000000000004023.
    >> Share

  40. RAO KD, Marklund M, Cherukupalli R, Yao Z, et al
    Health financing interventions and hypertension control: a narrative review and hypothetical model.
    J Hypertens. 2025 Apr 3. doi: 10.1097/HJH.0000000000004021.
    >> Share

  41. DANSER AHJ, Deinum J
    Antihypertensive drug treatment: are we ready for the future?
    J Hypertens. 2025 Apr 2. doi: 10.1097/HJH.0000000000004019.
    >> Share

  42. SACO-LEDO G, Ruilope LM, Lucia A
    Response to letter 'Are individuals with resistant hypertension not responsive to exercise when using ambulatory blood pressure monitoring?'.
    J Hypertens. 2025;43:725-726.
    >> Share

  43. SANTOS LP, Umpierre D
    Resistant hypertension and responsiveness to exercise in ambulatory blood pressure monitoring: concerns regarding a study by Saco-Ledo et al.
    J Hypertens. 2025;43:722-723.
    >> Share

  44. IATRIDI F, Theodorakopoulou MP, Georgiou A, Sarafidis PA, et al
    Understanding hypertension following solid organ transplantation: current trends and future perspectives.
    J Hypertens. 2025;43:720-721.
    >> Share

  45. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    In defense of beta-blockers: a critical role in primary hypertension management.
    J Hypertens. 2025;43:719-720.
    >> Share

  46. FORMAN R, Xin X, Kim C, Kernan WN, et al
    A failure to launch: blood pressure control after stroke in a regional health system.
    J Hypertens. 2025;43:715-718.
    >> Share

  47. SHARMAN JE, Takeuchi F, Protogerou A, Weber T, et al
    Prospective relationships between left ventricular mass, brachial and central blood pressures in participants from the UK Biobank.
    J Hypertens. 2025;43:698-704.
    >> Share

  48. ALMEIDA TP, Perruchoud D, Alexandre J, Vermare P, et al
    Evaluation of Aktiia cuffless blood pressure monitor across 24-h, daytime, and night-time measurements versus ambulatory monitoring: a prospective, single-centre observational study.
    J Hypertens. 2025;43:690-697.
    >> Share

    March 2025
  49. HARKNESS T, Wilkinson K, Loo YK, Howard VJ, et al
    Cell adhesion molecules and incident hypertension in black and white adults: the REGARDS study.
    J Hypertens. 2025 Mar 31. doi: 10.1097/HJH.0000000000004004.
    >> Share

  50. BENAVIDES-ROCA LA, Parra G, Zamuner AR
    Effects of a single session of low- and high-intensity velocity-based resistance exercise on blood pressure in patients with hypertension.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004015.
    >> Share

  51. GROVER S, Mishra HP, Gupta R, Gupta LK, et al
    Effect of telemonitoring and home blood pressure monitoring on blood pressure reduction in hypertensive adults: a network meta-analysis.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004008.
    >> Share

  52. KUNUTSOR SK, Connelly MA, Shah A, Bakker SJL, et al
    Associations of high-density lipoprotein cholesterol, particles and subspecies with the risk of hypertension: findings from the PREVEND prospective study.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004014.
    >> Share

  53. HUTTL M, Miklovic M, Gawrys O, Molnar M, et al
    The treatment with soluble guanylate cyclase stimulator BAY41-8543 prevents malignant hypertension and associated organ damage.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004009.
    >> Share

  54. GUO X, Qian J, Lai J, Wang H, et al
    Predictive value of pulmonary to systemic vascular resistance ratio in systemic lupus erythematosus patients with pulmonary arterial hypertension.
    J Hypertens. 2025 Mar 21. doi: 10.1097/HJH.0000000000004010.
    >> Share

  55. VERARDINO RGS, Macedo TA, Rodrigues S, Hong VC, et al
    Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease.
    J Hypertens. 2025 Mar 19. doi: 10.1097/HJH.0000000000003999.
    >> Share

  56. XU D, Liu H, Yang J
    Assessing causal relationships between gut microbiotas, metabolites, and pulmonary arterial hypertension through univariate Mendelian randomization study and bioinformatics analysis.
    J Hypertens. 2025 Mar 19. doi: 10.1097/HJH.0000000000004003.
    >> Share

  57. MIDDELKAMP M, Steffens PS, Vogelsang V, Schild R, et al
    Severe neurovascular hypertension in a 17-year-old girl cured by microvascular decompression.
    J Hypertens. 2025 Mar 10. doi: 10.1097/HJH.0000000000003986.
    >> Share

  58. XU XY, Zhang M, Qin Q, Xue R, et al
    KAT7 contributes to ponatinib-induced hypertension by promoting endothelial senescence and inflammatory responses through activating NF-kappaB signaling pathway.
    J Hypertens. 2025 Mar 10. doi: 10.1097/HJH.0000000000003979.
    >> Share

  59. PAOLETTI E, Ruotolo C, Marzano F, Borrelli S, et al
    The impact of left ventricular ejection fraction on cardiovascular and renal outcome in hypertensive patients with nondialysis chronic kidney disease.
    J Hypertens. 2025 Mar 7. doi: 10.1097/HJH.0000000000004000.
    >> Share

  60. MARUHASHI T, Kinoshita Y, Ozono R, Nakamura M, et al
    Nighttime blood pressure-targeted antihypertensive treatment.
    J Hypertens. 2025 Mar 6. doi: 10.1097/HJH.0000000000003998.
    >> Share

  61. DURUKAN BN, Ozcan EB, Saglam M, Sener YZ, et al
    Validity and reliability of the 6-min stepper test in hypertensive individuals.
    J Hypertens. 2025 Mar 6. doi: 10.1097/HJH.0000000000003996.
    >> Share

  62. KAUR A, Ricciardelli S, Rajah N, Pilote L, et al
    Sex differences in the association between hypertension, cerebral small vessel disease and cognitive decline: a narrative review.
    J Hypertens. 2025 Mar 3. doi: 10.1097/HJH.0000000000003997.
    >> Share

  63. WANG H, Zhou Z, Zhang L, Yu F, et al
    Sedentary behavior modified the association between depression and risk of all-cause deaths in hypertensive population.
    J Hypertens. 2025;43:474-480.
    >> Share

  64. DI GIOIA G, Ferrera A, Maestrini V, Monosilio S, et al
    Abnormal blood pressure response to exercise and ventricular arrhythmias: a suspicious association in athletes.
    J Hypertens. 2025;43:513-520.
    >> Share

  65. MOORTHY M, Kandula NR, Lancki N, Siddique J, et al
    Association of diastolic blood pressure and coronary artery calcium in South Asian American adults.
    J Hypertens. 2025;43:538-543.
    >> Share

  66. BYTYQI V, Kannenkeril D, Striepe K, Bosch A, et al
    Predicting blood pressure response to renal denervation based on a new approach.
    J Hypertens. 2025;43:413-419.
    >> Share

  67. ALVES MAM, Bezerra R, Dal Pont CS, Mota-Gomes MA, et al
    Relationship between blood pressure variability and blood pressure phenotypes: a home blood pressure monitoring study.
    J Hypertens. 2025;43:456-463.
    >> Share

    February 2025
  68. VOSKAMP LW, Rousian M, Koerts JJ, Steegers-Theunissen RPM, et al
    Risk factors for chronic hypertension 5 years after a pregnancy complicated by preeclampsia: a systematic review and meta-analysis.
    J Hypertens. 2025 Feb 28. doi: 10.1097/HJH.0000000000003995.
    >> Share

  69. WANG Y, Zhang Q, Shen C, Wang H, et al
    Decreased adenosine 3',5'-cyclic monophosphate is a driving factor of P300/SIRT1-mediated histone hyperacetylation in obesity-related hypertension.
    J Hypertens. 2025 Feb 28. doi: 10.1097/HJH.0000000000003981.
    >> Share

  70. CHEDDANI L, Lelong H, Goldberg M, Zins M, et al
    Prediction of incidence of hypertension in France and associated factors: results from the CONSTANCES cohort.
    J Hypertens. 2025 Feb 24. doi: 10.1097/HJH.0000000000003989.
    >> Share

  71. VAHTERA V, Pajarinen JS, Kivimaki M, Ervasti J, et al
    Incidence of new onset arterial hypertension after metabolic bariatric surgery: an 8-year prospective follow-up with matched controls.
    J Hypertens. 2025 Feb 24. doi: 10.1097/HJH.0000000000003993.
    >> Share

  72. DODULIK J, Dodulikova L, Plasek J, Ramik Z, et al
    Pharmacotherapy of arterial hypertension in patients with psoriasis.
    J Hypertens. 2025 Feb 18. doi: 10.1097/HJH.0000000000003982.
    >> Share

  73. KOLLER A, Jarai Z, Takacs J
    Development of the European Society of Hypertension guidelines for the management of arterial hypertension: comparison of the helpfulness of ESH 2013, 2018, and 2023 guidelines.
    J Hypertens. 2025 Feb 14. doi: 10.1097/HJH.0000000000003985.
    >> Share

  74. LI C, Wu S, Lei B, Zang W, et al
    Effect of aerobic exercise on endothelial function in hypertensive and prehypertensive patients: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2025 Feb 13. doi: 10.1097/HJH.0000000000003980.
    >> Share

  75. MORICONI D, Nannipieri M, Badhwar S, Taddei S, et al
    Impact of kidney function on stiffness of small conduit arteries in hypertension and obesity.
    J Hypertens. 2025 Feb 7. doi: 10.1097/HJH.0000000000003957.
    >> Share

  76. MARTIN A, Lang S, Schifferdecker F, Allo G, et al
    Nocturnal hypertension represents an uncontrolled burden in patients with metabolic dysfunction-associated steatotic liver disease.
    J Hypertens. 2025 Feb 4. doi: 10.1097/HJH.0000000000003977.
    >> Share


  77. The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2025;43:369.
    >> Share

  78. KAWADA T
    Self-rated health and clinical outcomes in patients with hypertension: a dose-response relationship.
    J Hypertens. 2025;43:365.
    >> Share

  79. OSAMA M, Ubaid S, Ullah U, Ubaid M, et al
    Serum neutrophil gelatinase-associated lipocalin and cystatin C as predictors of hypertension in ex-preterm children later in life.
    J Hypertens. 2025;43:364-365.
    >> Share

  80. LUE E, Shamilov DD, Lo DF
    Correspondence to "Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset".
    J Hypertens. 2025;43:362-363.
    >> Share

  81. POOS S, Hassan N, Jin S, Chuadhry I, et al
    A rheumatological perspective on hypertension: a role for disease-modifying antirheumatic drugs?
    J Hypertens. 2025;43:359-360.
    >> Share

  82. ALI MA, Zeng M, Alkuhali AA, Zeng Z, et al
    Toll-like receptor 4 inhibition by pyridostigmine is associated with a reduction in hypertension and inflammation in rat models of preeclampsia.
    J Hypertens. 2025;43:336-350.
    >> Share

  83. TAGETTI A, Cattazzo F, Marcon D, Romano S, et al
    Subclinical target organ damage in a sample of children and adolescents with solitary functioning kidney. A pilot study.
    J Hypertens. 2025;43:221-227.
    >> Share

  84. CAPPUCCIO FP, Manfredini R, Pigazzani F
    Chronotherapy of hypertension: let's not throw the baby out with the bathwater!
    J Hypertens. 2025;43:201-202.
    >> Share

  85. BANGALORE S, Maqsood MH, Bakris GL, Rao SV, et al
    Renal denervation - radiofrequency vs. ultrasound: insights from a mixed treatment comparison meta-analysis of randomized sham controlled trials.
    J Hypertens. 2025;43:325-335.
    >> Share

  86. WONG HJ, Toh KZX, Teo YH, Teo YN, et al
    Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials.
    J Hypertens. 2025;43:290-300.
    >> Share

  87. WANG M, Collings PJ, Jang H, Chen Z, et al
    Prospective associations of genetic susceptibility to high blood pressure and muscle strength with incident cardiovascular disease outcomes.
    J Hypertens. 2025;43:280-289.
    >> Share

  88. PATHAK A, Weber MA, Poulos C, Cohen SA, et al
    Impact of expected blood pressure reduction on patient preferences for pharmaceutical and renal denervation treatment.
    J Hypertens. 2025;43:228-235.
    >> Share

    January 2025
  89. NGUYEN DV, Pham GT, Pham SN, Nguyen HTT, et al
    Efficacy and safety of sacubitril-valsartan in hypertension patients with end-stage kidney disease on maintenance dialysis: a meta-analysis.
    J Hypertens. 2025 Jan 30. doi: 10.1097/HJH.0000000000003972.
    >> Share

  90. ORABONA R, Monaci R, Branca S, Sartorello S, et al
    Chronic hypertension in pregnancy: insights into adverse outcomes prevention.
    J Hypertens. 2025 Jan 30. doi: 10.1097/HJH.0000000000003978.
    >> Share

  91. NEMATI D, Noriega de la Colina AE, Wright KD, Joseph JJ, et al
    An I-Change approach to understanding exercise determinants among black individuals with hypertension.
    J Hypertens. 2025 Jan 28. doi: 10.1097/HJH.0000000000003974.
    >> Share

  92. CUSPIDI C, Facchetti R, Gherbesi E, Quarti-Trevano F, et al
    Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population.
    J Hypertens. 2025 Jan 23. doi: 10.1097/HJH.0000000000003970.
    >> Share

  93. ZHANG GY, Fan JR, Wang ZH, He Q, et al
    Treatment of early hypertensive renal damage with Quanduzhong capsules: two case reports.
    J Hypertens. 2025 Jan 23. doi: 10.1097/HJH.0000000000003966.
    >> Share

  94. MALOBERTI A, Rebora P, Occhino G, Andreano A, et al
    Carotid-femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes.
    J Hypertens. 2025 Jan 23. doi: 10.1097/HJH.0000000000003973.
    >> Share

  95. ALTIN CELIK P, Aytekin M
    Extracellular matrix dynamics in a rat model of pulmonary arterial hypertension: unveiling the role of hyaluronan in disease pathology.
    J Hypertens. 2025 Jan 17. doi: 10.1097/HJH.0000000000003967.
    >> Share

  96. STERGIOU GS, Kyriakoulis KG, Kollias A, McManus RJ, et al
    Blood pressure measurement at kiosks in public spaces: systematic review and consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability endorsed by the International Society of
    J Hypertens. 2025 Jan 14. doi: 10.1097/HJH.0000000000003965.
    >> Share

  97. FERRAO D, Nogueira-Silva L, Tavares S, Lima MJ, et al
    A case of renovascular hypertension due to polyarteritis nodosa.
    J Hypertens. 2025 Jan 3. doi: 10.1097/HJH.0000000000003963.
    >> Share


  98. Hypertension and obstructive sleep apnoea syndrome in adults with heart failure in nigeria: clinical correlates and association with clinical outcomes: Erratum.
    J Hypertens. 2025;43:183.
    >> Share

  99. KHAN S, Ahmad B, Khan MWZ, Fatima SM, et al
    Mechanisms of thiazide-induced hypertension treatment: insights from gene expression and histological analysis in malignant stroke-prone spontaneously hypertensive rats.
    J Hypertens. 2025;43:180-181.
    >> Share

  100. STECKO W, Wanczura P, Wajhajmer A, Wisniowski M, et al
    Chronic total occlusion of renal artery in symptomatic young patient with resistant hypertension: is a revascularization necessary or redundant?
    J Hypertens. 2025;43:163-167.
    >> Share

  101. WYATT N, Melhem N, Booth C, Newton J, et al
    Successful emergency renal auto-transplantation in a child with renovascular disease.
    J Hypertens. 2025;43:168-172.
    >> Share

  102. DE OLIVEIRA ESV, de Albuquerque NLS, Dordetto PR, Lamas JLT, et al
    Are previously validated blood pressure self-measurement devices accepted under the Universal Standard? A systematic review.
    J Hypertens. 2025;43:35-47.
    >> Share

  103. RECH JS, Postel-Vinay N, Vercamer V, de Villele P, et al
    User engagement with home blood pressure monitoring: a multinational cohort using real-world data collected with a connected device.
    J Hypertens. 2025;43:90-97.
    >> Share

  104. FAIENZA S, Citterio L, Messaggio E, Zagato L, et al
    A novel mouse model recapitulates the effects of rs2254524 variant in the lanosterol synthase gene on salt sensitivity and organ damage.
    J Hypertens. 2025;43:80-89.
    >> Share

  105. MAHMOUD AUM, Caillon A, Shokoples B, Ferreira NS, et al
    Vgamma6/Vdelta1 + gammadelta T cells protect from angiotensin II effects on blood pressure and endothelial function in mice.
    J Hypertens. 2025;43:109-119.
    >> Share

    December 2024
  106. RANASINGHE P, Manchanayake M, Perera T, Liyanage S, et al
    Prevalence and correlates of uncontrolled hypertension and cardiovascular morbidity among patients with hypertension at the largest tertiary care hospital in Sri Lanka.
    J Hypertens. 2024 Dec 23. doi: 10.1097/HJH.0000000000003952.
    >> Share

  107. RANASINGHE P, Perera T, Liyanage S, Manchanayake M, et al
    Hypertension in Sri Lanka: a systematic review of prevalence, control, care delivery and challenges.
    J Hypertens. 2024 Dec 20. doi: 10.1097/HJH.0000000000003953.
    >> Share

  108. KIM JH, Oh S, Hong SJ, Yu CW, et al
    Minimum number of readings necessary for determining long-term visit-to-visit blood pressure variability to predict cardiovascular outcomes in people with diabetes.
    J Hypertens. 2024 Dec 18. doi: 10.1097/HJH.0000000000003954.
    >> Share

  109. DE LA SIERRA A, Ruilope LM, Staplin N, Stergiou GS, et al
    Mortality risks in different subtypes of masked hypertension in the Spanish ambulatory blood pressure monitoring registry.
    J Hypertens. 2024 Dec 17. doi: 10.1097/HJH.0000000000003950.
    >> Share

  110. ZHENG Y, Zhong D, Li J, Zhang Y, et al
    Systemic immune-inflammation index and long-term mortality in patients with hypertension: a cohort study.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003927.
    >> Share

  111. YAO J, He X, Wang H, Wang A, et al
    Synergistic effect of anemia and obstructive sleep apnea on hypertension: National Health and Nutrition Examination Survey 2015-2018.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003939.
    >> Share

  112. TU Q, Hyun K, Lin S, Hafiz N, et al
    Impacts of hypertension and diabetes on the incidence of cardiovascular diseases and all-cause mortality: findings from the China Health and Retirement Longitudinal Study cohort.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003946.
    >> Share

  113. LEONE D, Vallelonga F, Botta M, Cesareo M, et al
    Heart failure with preserved ejection fraction: from echocardiographic characteristics to a cardiovascular damage score in a high-risk hypertensive population.
    J Hypertens. 2024 Dec 11. doi: 10.1097/HJH.0000000000003942.
    >> Share

  114. LEE K, Kim BS, Jeon J, Shin DW, et al
    Resolution of hypertension after kidney transplantation is associated with improved kidney transplant outcomes: a nationwide cohort study.
    J Hypertens. 2024 Dec 9. doi: 10.1097/HJH.0000000000003938.
    >> Share

  115. PINTO D, Teo A, Wijerethne S, Khoo CM, et al
    Remission of persistent hypertension and hypokalaemia following redo adrenalectomy for primary aldosteronism - case report.
    J Hypertens. 2024 Dec 9. doi: 10.1097/HJH.0000000000003944.
    >> Share

  116. SIMONYI G, Burnier M, Narkiewicz K, Rokszin G, et al
    Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis.
    J Hypertens. 2024 Dec 5. doi: 10.1097/HJH.0000000000003916.
    >> Share

  117. YSEBAERT L, Protin C, Oberic L, Beziat G, et al
    Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension.
    J Hypertens. 2024 Dec 4. doi: 10.1097/HJH.0000000000003937.
    >> Share

  118. BALDWIN J, Burnier M, Ponte B, Ackermann D, et al
    Association of mid-regional pro-adrenomedullin with office and 24-h ambulatory blood pressure in a Swiss general population sample.
    J Hypertens. 2024;42:2187-2195.
    >> Share

  119. INAGAKI Y, Matsushita K, Appel LJ, Perry HB, et al
    Task-sharing with community health workers to treat hypertension: a scoping review.
    J Hypertens. 2024;42:2041-2054.
    >> Share

  120. TCHIO C, Heydarpour M, Pojoga L, Taylor H, et al
    AGTR1 variant rs2638355 is associated with increased salt sensitivity of blood pressure: a female-specific effect in individuals from the HyperPath cohort.
    J Hypertens. 2024;42:2180-2186.
    >> Share

  121. WILLIAMS JR, Cole MA, Pewowaruk RJ, Hein AJ, et al
    Using an in-office passive leg raise to identify older adults with suboptimal blood pressure control.
    J Hypertens. 2024;42:2155-2163.
    >> Share

  122. TOMITANI N, Hoshide S, Kanegae H, Kario K, et al
    Daytime actisensitivity predicts nocturnal dipping patterns and morning surge in blood pressure: the Home-Activity ICT-based Japan Ambulatory Blood Pressure Monitoring Prospective study.
    J Hypertens. 2024;42:2164-2172.
    >> Share

  123. CHAINOGLOU A, Sarafidis K, Taparkou A, Farmaki E, et al
    Serum neutrophil gelatinase-associated lipocalin and cystatin C is associated with blood pressure in ex-preterm children and adolescents.
    J Hypertens. 2024;42:2196-2205.
    >> Share

    November 2024
  124. WEIHRAUCH T, Lemcke J, Buschges JC, Allen J, et al
    Participation interest and completion of home blood pressure measurements with mailed devices in adults with and without hypertension.
    J Hypertens. 2024 Nov 26. doi: 10.1097/HJH.0000000000003932.
    >> Share

  125. YUAN M, Zhang Y, Zuo N, Lei H, et al
    Association of oxidative balance score with blood pressure, all-cause and cardiovascular disease mortality among hypertensive patients: a prospective study.
    J Hypertens. 2024 Nov 21. doi: 10.1097/HJH.0000000000003931.
    >> Share

  126. SACO-LEDO G, Valenzuela PL, Almazan-Polo J, Plaza-Florido A, et al
    Acute physical exercise and ambulatory blood pressure in resistant hypertension.
    J Hypertens. 2024 Nov 12. doi: 10.1097/HJH.0000000000003924.
    >> Share

  127. DING C, Cao T, Cheng Z, Liu L, et al
    Independent and joint effect of central and brachial SBP on incident stroke in hypertensive adults.
    J Hypertens. 2024 Nov 6. doi: 10.1097/HJH.0000000000003921.
    >> Share

  128. AL-ANI A, Al Suleimani Y, Ritscher S, Toennes SW, et al
    Adherence to antihypertensive medications in Omani patients: a comparison of drug biochemical analysis and the Morisky Medication Adherence Scale.
    J Hypertens. 2024 Nov 4. doi: 10.1097/HJH.0000000000003917.
    >> Share

  129. PELES E, Schreiber S
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024;42:2020.
    >> Share

  130. WANG S, Wong SYS, Yip BHK, Lee EKP, et al
    Response to: Enhancing analytical approaches for investigating the age-dependent association of central blood pressure: UK biobank cohort study.
    J Hypertens. 2024;42:2019.
    >> Share

  131. BHATT R, Stepanyan A, Wasif U, Shamilov DD, et al
    Enhancing analytical approaches for investigating the age-dependent association of central blood pressure: UK biobank cohort study.
    J Hypertens. 2024;42:2018.
    >> Share

  132. THAPA N, Shamilov DD, Lo DF
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024;42:1895-1896.
    >> Share

  133. NILSSON PM, Pikkemaat M, Schutte AE
    Sustainable hypertension care - a new strategy for an expanding problem.
    J Hypertens. 2024;42:1891-1894.
    >> Share

  134. COCA A, Sebba-Barroso WK
    High blood pressure variability in middle age and cognitive decline in the elderly: the search for better predictors of dementia.
    J Hypertens. 2024;42:1889-1890.
    >> Share

  135. ZHANG R, Yin H, Yang M, Liu J, et al
    Advanced progress of the relationship between renin-angiotensin-aldosterone system inhibitors and cancers.
    J Hypertens. 2024;42:1862-1873.
    >> Share

  136. DONG S, Yu B, Yin C, Li Y, et al
    Associations between PM 2.5 and its chemical constituents and blood pressure: a cross-sectional study.
    J Hypertens. 2024;42:1897-1905.
    >> Share

  137. WU GJ, Si AM, Wang Y, Chu C, et al
    Associations of ultra long-term visit-to-visit blood pressure variability, since childhood with vascular aging in midlife: a 30-year prospective cohort study.
    J Hypertens. 2024;42:1948-1957.
    >> Share

  138. MELGAREJO JD, Vatcheva KP, Mejia-Arango S, Charisis S, et al
    Association of longitudinal changes in 24-h blood pressure level and variability with cognitive decline.
    J Hypertens. 2024;42:1985-1993.
    >> Share

  139. XU X, Catts VS, Harris K, Wang N, et al
    The contribution of cumulative blood pressure load to dementia, cognitive function and mortality in older adults.
    J Hypertens. 2024;42:1922-1931.
    >> Share

    October 2024
  140. ZHANG J, Wang J, Zhou X, Chen S, et al
    Serum autotaxin positively associates with hypertension in postmenopausal women: a single center study in China.
    J Hypertens. 2024 Oct 30. doi: 10.1097/HJH.0000000000003922.
    >> Share

  141. JAE SY, Yoon ES, Kim HJ, Cho MJ, et al
    Isometric handgrip versus aerobic exercise: a randomized trial evaluating central and ambulatory blood pressure outcomes in older hypertensive participants.
    J Hypertens. 2024 Oct 30. doi: 10.1097/HJH.0000000000003919.
    >> Share

  142. SANCHEZ R (CHAIR), Coca A (Co-Chair), de Salazar DIM, Alcocer L, et al
    2024 Latin American Society of Hypertension guidelines on the management of arterial hypertension and related comorbidities in Latin America.
    J Hypertens. 2024 Oct 25. doi: 10.1097/HJH.0000000000003899.
    >> Share

  143. ALKETBI LB, Al Hashaikeh B, Fahmawee T, Sahalu Y, et al
    Hypertension and its determinants in Abu Dhabi population: a retrospective cohort study.
    J Hypertens. 2024 Oct 24. doi: 10.1097/HJH.0000000000003907.
    >> Share

  144. MARTINHO LCAP, Zaniqueli D, Andreazzi AE, Oliveira CM, et al
    Association between early menarche and hypertension in pre and postmenopausal women: Baependi Heart Study.
    J Hypertens. 2024 Oct 17. doi: 10.1097/HJH.0000000000003908.
    >> Share

  145. BRGULJAN HITIJ J, Gaciong Z, Simic D, Vajer P, et al
    Differences in sex and age response to single pill combination based antihypertensive therapy reflecting in blood pressure and arterial stiffness.
    J Hypertens. 2024 Oct 17. doi: 10.1097/HJH.0000000000003901.
    >> Share

  146. SCHWOTZER N, Lu Y, Halfon M, Pascual M, et al
    Prevalence of hypertension and uncontrolled hypertension after solid organ transplantation: a 5-year follow-up of the Swiss Transplant Cohort Study.
    J Hypertens. 2024 Oct 17. doi: 10.1097/HJH.0000000000003905.
    >> Share

  147. BUZINARI TC, Castania JA, Salvador SLS, Ribeiro AB, et al
    Periodontitis accelerates the onset of hypertension in spontaneously hypertensive rats, while the electrical activation of the carotid sinus nerve delays the beginning of the increase in blood pressure.
    J Hypertens. 2024 Oct 14. doi: 10.1097/HJH.0000000000003906.
    >> Share

  148. WANG JX, Xu XY, Wang YM, Chen AD, et al
    Superior cervical ganglionectomy attenuates vascular remodeling in spontaneously hypertensive rats.
    J Hypertens. 2024 Oct 14. doi: 10.1097/HJH.0000000000003883.
    >> Share

  149. DE LUCA G, Nardin M, Algowhary M, Uguz B, et al
    Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry.
    J Hypertens. 2024 Oct 14. doi: 10.1097/HJH.0000000000003890.
    >> Share

  150. CALCADA A, Costa V, Ledo L, Freire P, et al
    Quick action required: revealing pheochromocytoma as the hidden trigger behind postoperative hypertensive crisis.
    J Hypertens. 2024 Oct 4. doi: 10.1097/HJH.0000000000003882.
    >> Share

  151. RING A, Lo DF
    Assessing coffee's impact on blood pressure: a critical examination of measurement and cultural variations.
    J Hypertens. 2024;42:1834-1836.
    >> Share

  152. MOTIEJUNAITE J, de Pinho NA, Flamant M, Vidal-Petiot E, et al
    Reply to 'Unmasking hypertension in patients with CKD: who to screen and how to confirm the diagnosis?'.
    J Hypertens. 2024;42:1833-1834.
    >> Share

  153. QUARTI-TREVANO F, Mancia G, Grassi G
    Assessing the association between coffee consumption and blood pressure values: when complexity prevails.
    J Hypertens. 2024;42:1832-1833.
    >> Share

  154. GEORGIANOS PI, Vaios V, Karligkiotis A, Liakopoulos V, et al
    Unmasking hypertension in patients with chronic kidney disease: who to screen and how to confirm the diagnosis?
    J Hypertens. 2024;42:1831-1832.
    >> Share

  155. KIM H, Lichtenstein AH, Coresh J, Appel LJ, et al
    Serum protein responses to Dietary Approaches to Stop Hypertension (DASH) and DASH-Sodium trials and associations with blood pressure changes.
    J Hypertens. 2024;42:1823-1830.
    >> Share

  156. RUIZ-SANCHEZ JG, Fernandez Sanchez A, Cardenas-Salas J, Fernandez-Cagigao Y, et al
    Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.
    J Hypertens. 2024;42:1813-1822.
    >> Share

  157. REBOLDI G, Angeli F, Verdecchia P
    Antihypertensive drugs in the morning or the evening? A complicated question with no clear answer.
    J Hypertens. 2024;42:1684-1686.
    >> Share

  158. LEE EK, Wang S, Ng WL, Ramdzan SN, et al
    Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials.
    J Hypertens. 2024;42:1653-1664.
    >> Share

  159. SATOH M, Metoki H, Kikuya M, Murakami T, et al
    Proposal of reference value for day-to-day blood pressure variability based on two outcomes: the Ohasama study.
    J Hypertens. 2024;42:1769-1776.
    >> Share

  160. PAN X, Chen Y, Yang Y, Kidambi S, et al
    Mediating effects of BMI on the association between DNA methylation regions and 24-h blood pressure in African Americans.
    J Hypertens. 2024;42:1750-1756.
    >> Share

  161. TABARA Y, Matsumoto T, Murase K, Setoh K, et al
    Sleep blood pressure measured using a home blood pressure monitor was independently associated with cardiovascular disease incidence: the Nagahama study.
    J Hypertens. 2024;42:1695-1702.
    >> Share

  162. BOULESTREAU R, Lorthioir A, Dreau H, Persu A, et al
    Baseline characteristics of the first 302 patients included for acute malignant hypertension crisis in the prospective multidisciplinary HAMA cohort.
    J Hypertens. 2024 Oct 1. doi: 10.1097/HJH.0000000000003851.
    >> Share

    September 2024
  163. FLOR AFL, Duarte-Maia S, Fernandes-Costa F, Souza RMP, et al
    Chronic cannabidiol treatment induces cardiovascular improvement in renovascular hypertensive rats.
    J Hypertens. 2024 Sep 30. doi: 10.1097/HJH.0000000000003865.
    >> Share

  164. ZHENG X, Zou P, Zeng C, Liu J, et al
    Increased levels of urine volatile organic compounds are associated with hypertension risk.
    J Hypertens. 2024 Sep 13. doi: 10.1097/HJH.0000000000003878.
    >> Share

  165. KIM HM, Hwang IC, Park J, Choi HJ, et al
    Impact of changes in left heart geometry on predicting new-onset atrial fibrillation in patients with hypertension.
    J Hypertens. 2024 Sep 12. doi: 10.1097/HJH.0000000000003875.
    >> Share

  166. CONNOLLY BJ, Saxton SN
    Recent updates on the influence of iron and magnesium on vascular, renal, and adipose inflammation and possible consequences for hypertension.
    J Hypertens. 2024 Sep 10. doi: 10.1097/HJH.0000000000003829.
    >> Share

  167. PALATINI P, Battista F, Mos L, Rattazzi M, et al
    Reproducibility of daytime hypertension, night-time hypertension, and nocturnal blood pressure dipping patterns in young to middle age patients with stage 1 hypertension.
    J Hypertens. 2024 Sep 10. doi: 10.1097/HJH.0000000000003874.
    >> Share

  168. KARIO K, Williams B, Tomitani N, McManus RJ, et al
    Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin Amer
    J Hypertens. 2024 Sep 9. doi: 10.1097/HJH.0000000000003827.
    >> Share

  169. BAHAT G, Ribeiro H, Sheppard JP, Bogaerts JMK, et al
    Twelve hot questions in the management of hypertension in patients aged 80+ years and their answers with the help of the 2023 European Society of Hypertension Guidelines.
    J Hypertens. 2024 Sep 5. doi: 10.1097/HJH.0000000000003844.
    >> Share

  170. DOKU A, Asamoah KT, Amaechi MU, Auala T, et al
    The development of Africa's first unified hypertension management guidelines.
    J Hypertens. 2024 Sep 2. doi: 10.1097/HJH.0000000000003864.
    >> Share

  171. KAZIBWE R, Muhammad AI, Singleton MJ, Evans JK, et al
    Self-rated health and risk of incident cardiovascular events among individuals with hypertension.
    J Hypertens. 2024;42:1573-1580.
    >> Share

  172. GREENSTEIN AS
    Don't forget to check your blood pressure.
    J Hypertens. 2024;42:1528.
    >> Share

  173. COTTRELL EC
    Commentary on: 'Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes'.
    J Hypertens. 2024;42:1523-1524.
    >> Share

  174. RUBIN S, Tomaszewski M
    Self-rated health in hypertension: navigating the complexities of cardiovascular risk prediction.
    J Hypertens. 2024;42:1521-1522.
    >> Share

  175. SALUJA S, Darlay R, Lennon R, Keavney BD, et al
    Whole -genome survival analysis of 144 286 people from the UK Biobank identifies novel loci associated with blood pressure.
    J Hypertens. 2024;42:1647-1652.
    >> Share

  176. ZHANG W, Li QY, Guo ZH, Zhang CY, et al
    Report on three cases of familial primary aldosteronism type IV.
    J Hypertens. 2024;42:1641-1646.
    >> Share

  177. HINDERLITER AL, Lin FC, Yang Y, Viera LA, et al
    The utility of home blood pressure load in predicting average self-measured blood pressure.
    J Hypertens. 2024;42:1624-1631.
    >> Share

  178. OMBONI S, Alfie J, Arystan A, Avolio A, et al
    Association of 24-h central hemodynamics and stiffness with cardiovascular events and all-cause mortality. The VASOTENS Registry.
    J Hypertens. 2024;42:1590-1597.
    >> Share

    August 2024
  179. AIZAWA K, Jordan AN, Gooding KM, Llewellyn DJ, et al
    Aortic reservoir-excess pressure parameters are associated with worse cognitive function in people with untreated stage II/III hypertension.
    J Hypertens. 2024 Aug 30. doi: 10.1097/HJH.0000000000003853.
    >> Share

  180. HAMDAN R, Baldassini AL, Vilcan A, Alan G, et al
    Finger SBP measurement as a way to manage hypertension in patients with markedly calcified arteries: a case report.
    J Hypertens. 2024 Aug 28. doi: 10.1097/HJH.0000000000003849.
    >> Share

  181. WANG X, Shaw JE, Yu J, Jennings G, et al
    Prevalence, awareness, treatment, and control rates of hypertension in the general population of Australia: a systematic review and meta-analysis.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003854.
    >> Share

  182. FERRARI R, Carpes LO, Domingues LB, Schneider VM, et al
    Recreational beach tennis training reduces ambulatory blood pressure in adults with hypertension: a randomized clinical trial.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003850.
    >> Share

  183. WANG N, Chalmers J, Harris K, Poulter N, et al
    Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003855.
    >> Share

  184. ASHENAGAR MS, Higashino T, Matsumoto A, Higashino H, et al
    Mechanisms of thiazide-induced hypertension treatment: insights from gene expression and histological analysis in malignant stroke-prone spontaneously hypertensive rats.
    J Hypertens. 2024 Aug 22. doi: 10.1097/HJH.0000000000003837.
    >> Share

  185. FRANCHI M, Torrigiani G, Kjeldsen SE, Mancia G, et al
    Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study.
    J Hypertens. 2024 Aug 14. doi: 10.1097/HJH.0000000000003841.
    >> Share

  186. KOVELL LC, Denu M, Revoori R, Sadaniantz K, et al
    Barriers and facilitators to home blood pressure monitoring in women with pregnancies complicated by hypertensive disorders: a qualitative study.
    J Hypertens. 2024 Aug 12. doi: 10.1097/HJH.0000000000003835.
    >> Share

  187. BAVARESCO GAMBASSI B, Schwingel PA
    Dynamic power training combined with endurance training reduces arterial stiffness and improves hemodynamic parameters in older adults diagnosed with grade 1 hypertension?
    J Hypertens. 2024;42:1461-1462.
    >> Share

  188. SALUJA S
    Reflections on the 2023 European Society of Hypertension summer school: a participant's perspective.
    J Hypertens. 2024;42:1460-1461.
    >> Share

  189. MA X, Zhuo Y, Zhang Z, Yang Y, et al
    Association of T-cell receptor repertoires and arterial stiffness in patients with essential hypertension.
    J Hypertens. 2024;42:1440-1448.
    >> Share

  190. DUPREZ DA, Jacobs DR Jr
    Hypertension and OMICS, quo vadis.
    J Hypertens. 2024;42:1307-1308.
    >> Share

  191. ZHANG Y, Sun Q, Yu C, Sun D, et al
    Associations of traditional cardiovascular risk factors with 15-year blood pressure change and trajectories in Chinese adults: a prospective cohort study.
    J Hypertens. 2024;42:1340-1349.
    >> Share

    July 2024
  192. NEMCSIK J, Takacs J, Kekk Z, Farsang C, et al
    White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry.
    J Hypertens. 2024 Jul 30. doi: 10.1097/HJH.0000000000003825.
    >> Share

  193. BOSCH A, Rauh M, Striepe K, Schiffer M, et al
    Renal adaptation in pre-obesity patients with hypertension.
    J Hypertens. 2024 Jul 22. doi: 10.1097/HJH.0000000000003821.
    >> Share

  194. SANCHEZ RA, Sanchez MJ, Pessana F, Ramirez AJ, et al
    Insulin resistance is associated to future hypertension in normotensive salt-sensitive individuals: a 10-year follow-up study.
    J Hypertens. 2024 Jul 15. doi: 10.1097/HJH.0000000000003810.
    >> Share

  195. LARKINS NG, Choong C, Schlaich M, Quinlan C, et al
    Defining childhood hypertension: is it too complicated? An evaluation of the potential impact of different approaches in an Australian paediatric population.
    J Hypertens. 2024 Jul 15. doi: 10.1097/HJH.0000000000003815.
    >> Share

  196. YAMANAKA K, Suzuki M, Pham LT, Tomita K, et al
    Involvement of D1 dopamine receptor in the nucleus of the solitary tract of rats in stress-induced hypertension and exercise.
    J Hypertens. 2024 Jul 5. doi: 10.1097/HJH.0000000000003809.
    >> Share

  197. KOS M, Nad T, Stupin A, Drenjancevic I, et al
    Juvenile primary hypertension is associated with attenuated macro- and microvascular dilator function independently of body weight.
    J Hypertens. 2024 Jul 5. doi: 10.1097/HJH.0000000000003812.
    >> Share

  198. MUNTNER P, Shimbo D, Schwartz JE
    Does nondipping blood pressure provide prognostic information for all-cause and cardiovascular mortality independent of nighttime blood pressure?
    J Hypertens. 2024;42:1151-1153.
    >> Share

  199. SAXENA M
    Vaccines against angiotensin receptors as a potential treatment for hypertension.
    J Hypertens. 2024;42:1150.
    >> Share

  200. SALUJA S, Lennon R
    Exploring novel therapeutic opportunities for hypertension: a paradigm-shifting approach via integrative multiomic analysis, pioneering the path to precision medicine.
    J Hypertens. 2024;42:1147-1149.
    >> Share

  201. MESSERLI FH, Schoenenberger-Berzins R, Messerli AW
    Why the lack of enthusiasm for renal denervation?
    J Hypertens. 2024;42:1145-1146.
    >> Share

  202. MANCIA G, Schumacher H, Bohm M, Grassi G, et al
    Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes.
    J Hypertens. 2024;42:1269-1281.
    >> Share

  203. AF GEIJERSTAM P, Radholm K, Jonasson L, Lindahl TL, et al
    P-selectin and C-reactive protein in relation to home blood pressure and coronary calcification: a SCAPIS substudy.
    J Hypertens. 2024;42:1226-1234.
    >> Share

  204. DE LA SIERRA A, Staplin N, Ruilope LM, Gorostidi M, et al
    A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortality.
    J Hypertens. 2024;42:1197-1202.
    >> Share

    June 2024
  205. SUN Y, Qi X, Wang X, Lin X, et al
    Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset.
    J Hypertens. 2024 Jun 26. doi: 10.1097/HJH.0000000000003803.
    >> Share

  206. YAP HJ, Lim JJJ, Tan SD, Ang CS, et al
    Effectiveness of digital health interventions on adherence and control of hypertension: a systematic review and meta-analysis.
    J Hypertens. 2024 Jun 25. doi: 10.1097/HJH.0000000000003793.
    >> Share

  207. PHAM MHC, Kuhl JT, Fuchs A, Sigvardsen PE, et al
    Determinants of thoracic aortic size in normotensive and hypertensive individuals.
    J Hypertens. 2024 Jun 25. doi: 10.1097/HJH.0000000000003792.
    >> Share

  208. KOH S, Kim D, Kim M, Kim T, et al
    Aerobic exercise effects on systolic blood pressure and endothelial inflammation in obese and non-obese elderly women with isolated systolic hypertension.
    J Hypertens. 2024 Jun 20. doi: 10.1097/HJH.0000000000003794.
    >> Share

  209. WANG J, Xu Y, Zhu J, Wu B, et al
    Multimodal data-driven, vertical visualization prediction model for early prediction of atherosclerotic cardiovascular disease in patients with new-onset hypertension.
    J Hypertens. 2024 Jun 18. doi: 10.1097/HJH.0000000000003798.
    >> Share

  210. WOJCIECHOWSKA W, Rajzer M, Kreutz R, Weber T, et al
    The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).
    J Hypertens. 2024 Jun 13. doi: 10.1097/HJH.0000000000003752.
    >> Share


  211. Dietary factors and hypertension risk in West Africa: a systematic review and meta-analysis of observational studies: Erratum.
    J Hypertens. 2024;42:1108.
    >> Share

  212. PEETERS LEJ, Koch BCP, Versmissen J
    Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.
    J Hypertens. 2024;42:1106-1107.
    >> Share

  213. RUBIN D, Lo DF, Jammula S, Carroll N, et al
    Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
    J Hypertens. 2024;42:1105-1106.
    >> Share

  214. MINETTO J, Cuello MB, Dominici FP, Caniffi C, et al
    Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension.
    J Hypertens. 2024;42:1101-1104.
    >> Share

  215. ZHOU YF, Ye YX, Chen JX, Zhang YB, et al
    Circulating metabolic biomarkers and risk of new-onset hypertension: findings from the UK Biobank.
    J Hypertens. 2024;42:1066-1074.
    >> Share

  216. CAMARGO LL, Trevelin SC, da Silva GHG, Dos Santos Dias AA, et al
    Protein disulfide isomerase-mediated transcriptional upregulation of Nox1 contributes to vascular dysfunction in hypertension.
    J Hypertens. 2024;42:984-999.
    >> Share

  217. KREUTZ R, Brunstrom M, Burnier M, Grassi G, et al
    Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern.
    J Hypertens. 2024;42:966-967.
    >> Share

  218. CHARCHAR FJ
    Wake up and enjoy the coffee without worrying about your blood pressure!
    J Hypertens. 2024;42:965.
    >> Share

  219. LATOSINSKA A, Siwy J, Mischak H
    Multiomics: paving the path towards personalized prevention of hypertension.
    J Hypertens. 2024;42:962-964.
    >> Share

  220. RUILOPE LM
    Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'.
    J Hypertens. 2024;42:961.
    >> Share

  221. TREVANO FQ, Vela-Bernal S, Facchetti R, Cuspidi C, et al
    Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study.
    J Hypertens. 2024;42:1094-1100.
    >> Share

  222. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
    Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
    J Hypertens. 2024;42:1009-1018.
    >> Share

  223. KOKKO E, Choudhary MK, Mutanen A, Honkonen M, et al
    Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study.
    J Hypertens. 2024;42:1057-1065.
    >> Share

  224. VRIEND EMC, Bouwmeester TA, Franco OH, Galenkamp H, et al
    Sex differences in blood pressure phenotypes over time - the HELIUS study.
    J Hypertens. 2024;42:977-983.
    >> Share

    May 2024
  225. XU J, Wang JJ, Zhao QH, Gong SG, et al
    Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension.
    J Hypertens. 2024 May 28. doi: 10.1097/HJH.0000000000003782.
    >> Share

  226. ZEIJEN VJM, Peeters LEJ, Asman A, Boersma E, et al
    Quality-of-life and beliefs about medication in relation to a therapy adherence intervention in resistant hypertension: the Resistant HYpertension: MEasure to ReaCh Targets trial.
    J Hypertens. 2024 May 24. doi: 10.1097/HJH.0000000000003780.
    >> Share

  227. ZHAO H, Wen P, Xu Q, Zi Y, et al
    Association of sleep traits with risk of hypertensive disorders of pregnancy: a mendelian randomization study.
    J Hypertens. 2024 May 22. doi: 10.1097/HJH.0000000000003771.
    >> Share

  228. GRASSI G
    Thirty-five years of the European Society of Hypertension: from past to future.
    J Hypertens. 2024 May 22. doi: 10.1097/HJH.0000000000003778.
    >> Share

  229. DORDEVIC DB, Koracevic GP, Dordevic AD, Lovic DB, et al
    Hypertension and left ventricular hypertrophy.
    J Hypertens. 2024 May 16. doi: 10.1097/HJH.0000000000003774.
    >> Share

  230. SCHLAICH MP, Tsioufis K, Taddei S, Ferri C, et al
    Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003769.
    >> Share

  231. SHAHRBABAKI SS, Liu X, Baumert M
    Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003775.
    >> Share

  232. HALIMI JM, Sarafidis P, Azizi M, Bilo G, et al
    Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire.
    J Hypertens. 2024 May 14. doi: 10.1097/HJH.0000000000003756.
    >> Share

  233. ROSSI GP, Bagordo D, Rossi FB, Pintus G, et al
    'Essential' arterial hypertension: time for a paradigm change.
    J Hypertens. 2024 May 9. doi: 10.1097/HJH.0000000000003767.
    >> Share

  234. CHEN Z, Wei D, Zhao M, Shi J, et al
    Associations of serum glucocorticoid levels on hypertension and blood pressure-related indicators: a nested case-control study in rural China.
    J Hypertens. 2024 May 8. doi: 10.1097/HJH.0000000000003758.
    >> Share

  235. HUA D, Huang W, Huang W, Xie Q, et al
    TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
    J Hypertens. 2024 May 2. doi: 10.1097/HJH.0000000000003748.
    >> Share

  236. CASIGLIA E
    AND, OR, AND/OR in hypertension guidelines.
    J Hypertens. 2024;42:934-935.
    >> Share

  237. HUTCHINGS DC, Heagerty AM
    Sleeping unsoundly: CPAP and its complexities in treating sleep apnoea hypertension.
    J Hypertens. 2024;42:766-767.
    >> Share

  238. BRASIL IA, Silva JCPL, Pescatello LS, Farinatti P, et al
    Central and peripheral mechanisms underlying postexercise hypotension: a scoping review.
    J Hypertens. 2024;42:751-763.
    >> Share

  239. WANG S, Wong SYS, Yip BHK, Lee EKP, et al
    Age-dependent association of central blood pressure with cardiovascular outcomes: a cohort study involving 34 289 participants using the UK biobank.
    J Hypertens. 2024;42:769-776.
    >> Share

  240. CELLER BG, Yong A, Rubenis I, Butlin M, et al
    Accurate detection of Korotkoff sounds reveals large discrepancy between intra-arterial systolic pressure and simultaneous noninvasive measurement of blood pressure with brachial cuff sphygmomanometry.
    J Hypertens. 2024;42:873-882.
    >> Share

  241. NATALE P, Palmer SC, Jaure A, Saglimbene V, et al
    Blood pressure lowering for kidney transplant recipients: systematic review with network meta-analysis.
    J Hypertens. 2024;42:848-855.
    >> Share

  242. SESA-ASHTON G, Carnagarin R, Nolde JM, Muente I, et al
    Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation.
    J Hypertens. 2024;42:922-927.
    >> Share

    April 2024
  243. WANG JG, Topouchian J, Bricout-Hennel S, Mu J, et al
    Efficacy and safety of a single-pill versus free combination of perindopril/indapamide/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension.
    J Hypertens. 2024 Apr 25. doi: 10.1097/HJH.0000000000003741.
    >> Share

  244. XU ZQ, Li XZ, Zhu R, Ge R, et al
    Asprosin contributes to vascular remodeling in hypertensive rats via superoxide signaling.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003751.
    >> Share

  245. FARAH BQ, Forjaz CLM, O'Driscoll JM, Millar PJ, et al
    Characteristics associated with responsiveness to isometric handgrip training in medicated hypertensive patients: secondary data analysis.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003749.
    >> Share

  246. HUGHES AD, Davey Smith G, Howe LD, Lawlor D, et al
    Differences between brachial and aortic blood pressure in adolescence and their implications for diagnosis of hypertension.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003743.
    >> Share

  247. CHE J, Tong J, Kuang X, Zheng C, et al
    Hyperuricemia and gout enhanced the risk of long-term mortality in hypertension: insights from the National Health and Nutrition Examination Survey 2007-2018.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003744.
    >> Share

  248. SHANTSILA E, Beevers DG, Lip GYH
    For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003733.
    >> Share

  249. SHARP ASP, Sanderson A, Hansell N, Reddish K, et al
    Renal denervation for uncontrolled hypertension: a systematic review and meta-analysis examining multiple subgroups.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003727.
    >> Share

  250. THOMOPOULOS C, Hitij JB, De Backer T, Gkaliagkousi E, et al
    Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003739.
    >> Share

  251. PALERMITI A, Pappaccogli M, Rabbia F, D'Avolio A, et al
    Multiple drug intolerance in antihypertensive patients: what is known and what is missing.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003737.
    >> Share

  252. SASON A, Adelson M, Leshno D, Schreiber S, et al
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024 Apr 11. doi: 10.1097/HJH.0000000000003740.
    >> Share

  253. KYRIAKOULIS KG, Kollias A, Bilo G, Soranna D, et al
    Blood pressure variability assessed by office, home, and ambulatory measurements before and during antihypertensive drug treatment: a sub-analysis of the REVERENT randomized trial.
    J Hypertens. 2024 Apr 5. doi: 10.1097/HJH.0000000000003730.
    >> Share

  254. KEISER T, Katz S, Robson SM, Greaney JL, et al
    Association between time-of-day for eating, exercise, and sleep with blood pressure in adults with elevated blood pressure or hypertension: a systematic review.
    J Hypertens. 2024 Apr 3. doi: 10.1097/HJH.0000000000003732.
    >> Share

  255. BAVARESCO GAMBASSI B, Chaves LFC, Sousa TMDS, Ribeiro MJS, et al
    Short-duration dynamic power training with elastic bands combined with endurance training: a promising approach to hypertension management in older adults.
    J Hypertens. 2024;42:735-742.
    >> Share

  256. FERREIRA MJ, Dias DDS, Silva GDC, de Araujo AA, et al
    Concurrent exercise training potentiates the effects of angiotensin-converting enzyme inhibitor on regulatory systems of blood pressure control in ovariectomized hypertensive rats.
    J Hypertens. 2024;42:650-661.
    >> Share

  257. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals.
    J Hypertens. 2024;42:610-619.
    >> Share

  258. SALUJA S
    A critical commentary on the use of combined power and endurance training for hypertension management in older adults.
    J Hypertens. 2024;42:605-606.
    >> Share

  259. BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
    Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus.
    J Hypertens. 2024;42:583-593.
    >> Share

  260. ZHOU T, Gu S, Shao F, Li P, et al
    Prediction of preeclampsia from retinal fundus images via deep learning in singleton pregnancies: a prospective cohort study.
    J Hypertens. 2024;42:701-710.
    >> Share

  261. ASTUDILLO Y, Kibrom S, Pereira T, Solomon S, et al
    Association between anxiety and elevated blood pressure in adolescent patients: a single-center cross-sectional study.
    J Hypertens. 2024;42:644-649.
    >> Share

  262. WADA A, Kabayama M, Godai K, Kido M, et al
    Factors influencing the continuation of home blood pressure measurement in community-dwelling older adults: the NOSE study.
    J Hypertens. 2024;42:694-700.
    >> Share

    March 2024
  263. MAVROGEORGIS E, Kondyli M, Mischak H, Vlahou A, et al
    Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
    J Hypertens. 2024 Mar 29. doi: 10.1097/HJH.0000000000003726.
    >> Share

  264. BERILLO O, Comeau K, Caillon A, Leclerc S, et al
    CD28-expressing delta T cells are increased in perivascular adipose tissue of hypertensive mice and in subcutaneous adipose tissue of obese humans.
    J Hypertens. 2024 Mar 27. doi: 10.1097/HJH.0000000000003725.
    >> Share

  265. LIN J, Costa JO, Pearson SA, Buckley NA, et al
    Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia.
    J Hypertens. 2024 Mar 14. doi: 10.1097/HJH.0000000000003721.
    >> Share

  266. WANG Z, Li W, Jiang C, Wang J, et al
    Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003715.
    >> Share

  267. WU J, Wu Z, Kuang W, Shi D, et al
    Combined vaccines against angiotensin II receptor type 1 and alpha 1D-adrenergic receptor for hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003710.
    >> Share

  268. GUO J, Jia P, Gu Z, Tang W, et al
    Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003716.
    >> Share

  269. PALATINI P, Kollias A, Saladini F, Asmar R, et al
    Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2024 Mar 4. doi: 10.1097/HJH.0000000000003704.
    >> Share

  270. WATZ MES, Tivesten A, Ottarsdottir K, Li Y, et al
    Reply on: Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:580-581.
    >> Share

  271. PATEL J, Amin K, Lo DF
    Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:579-580.
    >> Share

  272. ZHENG X, Lei Y, Cheng XW
    Resolvin D1 as a novel target in the management of hypertension.
    J Hypertens. 2024;42:393-395.
    >> Share

  273. KOLLIAS A, Kyriakoulis KG, Komnianou A, Stathopoulou P, et al
    Prognostic value of home versus ambulatory blood pressure monitoring: a systematic review and meta-analysis of outcome studies.
    J Hypertens. 2024;42:385-392.
    >> Share

  274. NAITO Y, Yasumura S, Okuno K, Asakura M, et al
    Hypoxia-inducible factor-prolyl hydroxylase inhibitor Roxadustat (FG-4592) reduces renal fibrosis in Dahl salt-sensitive rats.
    J Hypertens. 2024;42:497-505.
    >> Share

  275. LOO G, Puar T, Foo R, Ong TK, et al
    Unique characteristics of Asians with hypertension: what is known and what can be done?
    J Hypertens. 2024 Mar 1. doi: 10.1097/HJH.0000000000003706.
    >> Share

    February 2024
  276. BERSCH-FERREIRA AC, Machado RHV, de Oliveira JS, Santos RHN, et al
    Effectiveness of a two-component nutritional strategy for blood pressure control in individuals with hypertension users of a public health system: a randomized controlled clinical trial.
    J Hypertens. 2024 Feb 26. doi: 10.1097/HJH.0000000000003703.
    >> Share

  277. LANG X, Peng C, Zhang Y, Gao R, et al
    Correlation between systolic blood pressure and mortality in heart failure patients with hypertension.
    J Hypertens. 2024 Feb 16. doi: 10.1097/HJH.0000000000003693.
    >> Share

  278. CARRY BJ, Miller WL
    Blood volume phenotypes and patient sex in resistant hypertension.
    J Hypertens. 2024 Feb 15. doi: 10.1097/HJH.0000000000003688.
    >> Share

  279. LEGRAND F, Motiejunaite J, Arnoult F, Lahens A, et al
    Prevalence and factors associated with masked hypertension in chronic kidney disease.
    J Hypertens. 2024 Feb 12. doi: 10.1097/HJH.0000000000003680.
    >> Share

  280. RAMIREZ-CARRACEDO R, Hernandez I, Moreno-Gomez-Toledano R, Diez-Mata J, et al
    NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.
    J Hypertens. 2024 Feb 6. doi: 10.1097/HJH.0000000000003679.
    >> Share

  281. CHUNNAN L, Shaomei S, Wannian L
    Sleep and risk of hypertension in general American adults: reply.
    J Hypertens. 2024;42:382-383.
    >> Share

  282. SCORZA FA, Bombardi LM, de Almeida AG, Finsterer J, et al
    Hypertension: the dramatic rise in dangerous pesticides found on fruits and vegetables.
    J Hypertens. 2024;42:381-382.
    >> Share

  283. GUAN T, Cao M, Zheng C, Zhou H, et al
    Dose-response association between physical activity and blood pressure among Chinese adults: a nationwide cross-sectional study.
    J Hypertens. 2024;42:360-370.
    >> Share

  284. FRAVEL MA, Ernst ME, Woods RL, Beilin L, et al
    Long-term blood pressure variability and frailty risk in older adults.
    J Hypertens. 2024;42:244-251.
    >> Share

  285. KARELIUS S, Pentti J, Juhanoja E, Jula A, et al
    Association of work-related psychosocial factors and day-to-day home blood pressure variation: the Finn-Home study.
    J Hypertens. 2024;42:337-343.
    >> Share

  286. NEWTON J, Haseler E, Higgins C, Futcher C, et al
    Reliability of systolic blood pressure measured by parents in young children at home using a hand held doppler device and aneroid sphygmomanometer.
    J Hypertens. 2024;42:308-314.
    >> Share

  287. ZAMAN S, Raj IS, Yang AWH, Lindner R, et al
    Exercise training reduces arterial stiffness in women with high blood pressure: a systematic review and meta-analysis.
    J Hypertens. 2024;42:197-204.
    >> Share

  288. LIU N, Gong Z, Li Y, Xu Y, et al
    CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats.
    J Hypertens. 2024;42:315-328.
    >> Share

  289. MARQUES ER, Bernardino AC, Alvim RO, Schreiber R, et al
    Relationship of blood pressure measured in the calf with arm blood pressure and arterial stiffness: a general population study.
    J Hypertens. 2024;42:301-307.
    >> Share

  290. ZHANG L, Wang W, Gong J, Wang X, et al
    Development, validation, and clinical utility of a risk prediction model for recurrent preeclampsia.
    J Hypertens. 2024;42:236-243.
    >> Share

    January 2024
  291. SAGARA K, Goto K, Maeda M, Murata F, et al
    Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the life study.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003661.
    >> Share

  292. YE XF, Wang WY, Wang XY, Huang QF, et al
    Seasonal variation in ambulatory blood pressure control in patients on clinic blood pressure-guided antihypertensive treatment.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003666.
    >> Share

  293. EGAN BM, Li J, Sutherland SE, Rakotz MK, et al
    Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003656.
    >> Share

  294. KIM BS, Lee Y, Shin JH, Heo R, et al
    Blood pressure and variability responses to the down-titration of antihypertensive drugs.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003668.
    >> Share

  295. OKEKUNLE AP, Asowata OJ, Akpa OM, Fakunle AG, et al
    Dietary patterns associated with hypertension among stroke-free indigenous Africans: insights from the Stroke Investigative Research and Educational Network study.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003662.
    >> Share


  296. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Asso
    J Hypertens. 2024;42:194.
    >> Share

  297. ABDELAZEEM B, Saleh O, Mahmoud A, Abuelazm M, et al
    Authors' response to "Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings".
    J Hypertens. 2024;42:191-192.
    >> Share

  298. FERNANDEZ JR, Mojon A, Smolensky MH, Hermida RC, et al
    Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings.
    J Hypertens. 2024;42:190-191.
    >> Share

  299. KREUTZ R, Palatini P, Stergiou G, Mancia G, et al
    Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?
    J Hypertens. 2024;42:188-189.
    >> Share

  300. PAIVA AMG, Gomes MICM, Silva EAA, Feitosa ADM, et al
    Should arm positioning matter in the diagnosis of orthostatic hypotension and hypertension?
    J Hypertens. 2024;42:186-188.
    >> Share

  301. ARMANINI D, Sabbadin C, Manso J, Boscaro M, et al
    Consideration in the evaluation of follow-up of resistant hypertension.
    J Hypertens. 2024;42:56-57.
    >> Share

  302. OSCULLO G, Gomez-Olivas JD, Martinez-Garcia MA
    Nocturnal hypertension phenotypes and obstructive sleep apnoea.
    J Hypertens. 2024;42:50-52.
    >> Share

  303. RABBITT L, Curneen J, Hobbins A, Browne D, et al
    A cost-analysis of managing secondary and apparent treatment-resistant hypertension in a specialist multidisciplinary hypertension clinic.
    J Hypertens. 2024;42:58-69.
    >> Share

  304. KISHI T
    Gender differences in the association of serum uric acid with left ventricular hypertrophy should be focused.
    J Hypertens. 2024;42:53-55.
    >> Share

  305. OSMAN MMA, Mullins E, Kleprlikova H, Wilkinson IB, et al
    Beetroot juice, exercise, and cardiovascular function in women planning to conceive.
    J Hypertens. 2024;42:101-108.
    >> Share

  306. SNYMAN JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, et al
    A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    J Hypertens. 2024;42:136-142.
    >> Share

  307. SHANTSILA E, Shantsila A, Williams N, Lip GYH, et al
    Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.
    J Hypertens. 2024;42:95-100.
    >> Share

  308. GHERBESI E, Faggiano A, Sala C, Carugo S, et al
    Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies.
    J Hypertens. 2024;42:109-117.
    >> Share

  309. PANAGIOTAKOS D, Antza C, Kotsis V
    Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies.
    J Hypertens. 2024;42:1-9.
    >> Share

    December 2023
  310. GIBSON R, Aljuraiban GS, Oude-Griep LM, Vu TH, et al
    Relationship of calcium and magnesium intakes with the dietary approaches to stop hypertension score and blood pressure: the International Study of Macro/micronutrients and Blood Pressure.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003648.
    >> Share

  311. GAN J, Shi Y, Zhao R, Li D, et al
    Adipose c-Jun NH2-terminal kinase promotes angiotensin II-induced and deoxycorticosterone acetate salt-induced hypertension and vascular dysfunction by inhibition of adiponectin production and activation of SGK1 in mice.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003649.
    >> Share

  312. WANG L, Li C, Li Z, Li Q, et al
    Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003650.
    >> Share

  313. SERRA MO, de Macedo LR, Silva M, Lautner RQ, et al
    Effect of Vitamin D supplementation on blood pressure in hypertensive individuals with hypovitaminosis D: a systematic review and meta-analysis.
    J Hypertens. 2023 Dec 19. doi: 10.1097/HJH.0000000000003646.
    >> Share

  314. SATHEESH G, Dhurjati R, Huffman MD, Rosende A, et al
    Standardized treatment protocols for hypertension: global availability, characteristics, and alignment with the hypertension guideline recommendations.
    J Hypertens. 2023 Dec 18. doi: 10.1097/HJH.0000000000003636.
    >> Share

  315. SALMAN UA, Schwartz JG, McMahan AC, Michalek JE, et al
    Rapid Gastric emptying in spontaneously hypertensive rats.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003640.
    >> Share

  316. SASAGAWA Y, Inoue Y, Futagami K, Nakamura T, et al
    Application of deep neural survival networks to the development of risk prediction models for diabetes mellitus, hypertension, and dyslipidemia.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003626.
    >> Share

  317. CIFKOVA R, Harazny JM, Bruthans J, Wohlfahrt P, et al
    Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003637.
    >> Share

  318. CRUZ-LOPEZ EO, Ye D, Stolk DG, Clahsen-van Groningen MC, et al
    Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effects.
    J Hypertens. 2023 Dec 11. doi: 10.1097/HJH.0000000000003633.
    >> Share

  319. ATASOY S, Henningsen P, Johar H, Middeke M, et al
    Hypertension in the first blood pressure reading and the risk of cardiovascular disease mortality in the general population: findings from the prospective KORA study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003629.
    >> Share

  320. KIM Y, Kim J, Kang E, Im DW, et al
    The association of time-updated ambulatory blood pressure and renal progression in hypertensive patients with chronic kidney disease: post hoc analysis of ACCURATE study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003625.
    >> Share

  321. BOTHE TL, Kreutz R, Glos M, Patzak A, et al
    Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003632.
    >> Share

  322. THOMOPOULOS C
    Target blood pressure in isolated systolic hypertension: a meta-analysis of randomized outcome trials.
    J Hypertens. 2023;41:2113-2114.
    >> Share

  323. RAM CVS
    The latest hypertension guidelines: from encryption to decryption, finally!
    J Hypertens. 2023;41:2072-2073.
    >> Share

    November 2023
  324. NAKAGAWA K, Chen R, Ross GW, Donlon TA, et al
    FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk.
    J Hypertens. 2023 Nov 23. doi: 10.1097/HJH.0000000000003620.
    >> Share

  325. XIONG Y, He Y, Chen Z, Wu T, et al
    Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.
    J Hypertens. 2023 Nov 17. doi: 10.1097/HJH.0000000000003613.
    >> Share

  326. HALE G, Puchades E, Jacomino G, El-Mcharfie L, et al
    Use trends of chlorthalidone and hydrochlorothiazide among United States adults with hypertension: National Health and Nutrition Examination Survey 2009-2018.
    J Hypertens. 2023 Nov 16. doi: 10.1097/HJH.0000000000003622.
    >> Share

  327. KIM JH, Joo HJ, Chung SH, Yum Y, et al
    Cardiovascular outcomes according to on-treatment systolic blood pressure in older hypertensive patients: a multicenter cohort using a common data model.
    J Hypertens. 2023 Nov 15. doi: 10.1097/HJH.0000000000003544.
    >> Share

  328. BUDZYN M, Gryszczynska B, Begier-Krasinska B, Kaja E, et al
    Decreased toll-like receptor 4 and CD11b/CD18 expression on peripheral monocytes of hypertensive patients correlates with a lesser extent of endothelial damage: a preliminary study.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003617.
    >> Share

  329. JOYCE OC, McHugh C, Mockler D, Wilson F, et al
    Midlife hypertension is a risk factor for some, but not all, domains of cognitive decline in later life: a systematic review and meta-analysis.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003614.
    >> Share

  330. STEFANI LD, Trivedi SJ, Ferkh A, Emerson P, et al
    Left atrial mechanics evaluated by two-dimensional strain analysis: alterations in essential hypertension.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003615.
    >> Share

  331. WEI C, Zhang J, Peng S, Liu J, et al
    Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway.
    J Hypertens. 2023 Nov 7. doi: 10.1097/HJH.0000000000003610.
    >> Share

  332. QIU W, Cai A, Li L, Feng Y, et al
    Association of depression trajectories and subsequent hypertension and cardiovascular disease: findings from the CHARLS cohort.
    J Hypertens. 2023 Nov 2. doi: 10.1097/HJH.0000000000003609.
    >> Share


  333. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    J Hypertens. 2023;41:1872.
    >> Share


  334. Prevalence of non-steroidal anti-inflammatory drugs (NSAIDS) use in patients with hypertensive crisis: Erratum.
    J Hypertens. 2023;41:1871.
    >> Share


  335. PS-P12-8: The prevalence of hypertension in factory employees, detected during the periodic examination at the factory: Erratum.
    J Hypertens. 2023;41:1868.
    >> Share

  336. TABARA Y
    Reply to 'Phenotyping sleep hypertension; never forgetting the night'.
    J Hypertens. 2023;41:1867.
    >> Share

  337. CUSPIDI C, Gherbesi E, Tadic M
    Phenotyping masked hypertension: do not forget the night.
    J Hypertens. 2023;41:1865-1866.
    >> Share

  338. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.
    J Hypertens. 2023;41:1864-1865.
    >> Share

  339. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    Reply to 'Examining the impact of E-health management on hypertension'.
    J Hypertens. 2023;41:1864.
    >> Share

  340. FATIMA HE, Lo DF
    Examining the impact of E-health management on hypertension.
    J Hypertens. 2023;41:1863.
    >> Share

  341. CARDOSO AM, Aneli NM, Lammers M, Manica A, et al
    Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling.
    J Hypertens. 2023;41:1745-1752.
    >> Share

  342. SHI M, Liu Y, Wang S, Wang R, et al
    Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke.
    J Hypertens. 2023;41:1730-1737.
    >> Share

  343. SHOKOPLES BG, Berillo O, Comeau K, Chen HY, et al
    P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation.
    J Hypertens. 2023;41:1701-1712.
    >> Share

  344. SULICKA-GRODZICKA J, Guzik TJ
    The ATP connection: a new therapeutic promise of P2X7 targeting in hypertension and vascular injury.
    J Hypertens. 2023;41:1696-1698.
    >> Share

  345. SONG J, Tan M, Wang C, Brown MK, et al
    Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
    J Hypertens. 2023;41:1713-1720.
    >> Share

  346. SCHMIDT-LAUBER C, Alba Schmidt E, Hanzelmann S, Petersen EL, et al
    Increased blood pressure after nonsevere COVID-19.
    J Hypertens. 2023;41:1721-1729.
    >> Share

  347. LEE SH, Lee CJ, Kang Y, Park JM, et al
    A randomized trial of genotype-guided perindopril use.
    J Hypertens. 2023;41:1768-1774.
    >> Share

  348. WIERSINGA JHI, Rhodius-Meester HFM, Wolters FJ, Trappenburg MC, et al
    Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population.
    J Hypertens. 2023;41:1738-1744.
    >> Share


  349. Skin NA+, K+ and water before and after surgical cure of human primary aldosteronism: Erratum.
    J Hypertens. 2023;41:1869.
    >> Share

  350. FENG L, Ye Z, Mo C, Wang J, et al
    Elevated blood pressure accelerates white matter brain aging among late middle-aged women: a Mendelian Randomization study in the UK Biobank.
    J Hypertens. 2023;41:1811-1820.
    >> Share

  351. ZHANG X, Zhou Y, Yang J, Wang Y, et al
    Trend of blood pressure changes among children from 2012 to 2022: findings from student health surveillance in Eastern China.
    J Hypertens. 2023;41:1821-1830.
    >> Share

  352. YOUNIS D, Mosbah A, Zakaria MM, Awadalla A, et al
    Urinary congophilia in pregnancy: a marker of kidney injury rather than preeclampsia.
    J Hypertens. 2023;41:1760-1767.
    >> Share

    October 2023
  353. ZAHNER MR, Brown MC, Chandley MJ
    Inactivation of the paraventricular nucleus attenuates the cardiogenic sympathetic afferent reflex in the spontaneously hypertensive rat.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003542.
    >> Share

  354. GHAZI L, Cohen JB, Townsend RR, Drawz PE, et al
    Orthostatic hypotension, orthostatic hypertension, and ambulatory blood pressure in patients with chronic kidney disease in CRIC.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003604.
    >> Share

  355. MA H, Wang C, Jiang M, Jin K, et al
    Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension.
    J Hypertens. 2023 Oct 23. doi: 10.1097/HJH.0000000000003601.
    >> Share

  356. KASANAGOTTU K, Mukamal KJ, Landon BE
    Predictors of treatment intensification in uncontrolled hypertension.
    J Hypertens. 2023 Oct 20. doi: 10.1097/HJH.0000000000003598.
    >> Share

  357. SASAKI N, Ueno Y, Ozono R, Yoshimura K, et al
    Association of serum uric acid levels with blood pressure and the incidence of hypertension in the middle-aged and elderly populations.
    J Hypertens. 2023 Oct 12. doi: 10.1097/HJH.0000000000003597.
    >> Share

  358. ARAUJO-CASTRO M, Garcia Sanz I, Minguez Ojeda C, Hanzu F, et al
    Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
    J Hypertens. 2023 Oct 11. doi: 10.1097/HJH.0000000000003596.
    >> Share

  359. MANCIA G, Facchetti R, Quarti-Trevano F, Dell'Oro R, et al
    Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003582.
    >> Share

  360. LI M, Qu K, Wang Y, Wang Y, et al
    Associations of hypertensive disorders of pregnancy with cognition, dementia, and brain structure: a Mendelian randomization study.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003593.
    >> Share

  361. PEETERS LEJ, Kappers MHW, Hesselink DA, van der Net JB, et al
    Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003585.
    >> Share

  362. RIJAL A, Adhikari TB, Dhakal S, Maagaard M, et al
    Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003589.
    >> Share

  363. BROSOLO G, Da Porto A, Bulfone L, Vacca A, et al
    Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003590.
    >> Share

  364. BASTA K, Ledwaba-Chapman L, Dodhia H, Ashworth M, et al
    Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021.
    J Hypertens. 2023 Oct 2. doi: 10.1097/HJH.0000000000003584.
    >> Share

    September 2023
  365. DE LA SIERRA A, Ruilope LM, Martinez-Camblor P, Vinyoles E, et al
    Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.
    J Hypertens. 2023 Sep 27. doi: 10.1097/HJH.0000000000003581.
    >> Share

  366. DUTRA RT, Bensenor IM, Goulart AC, Pereira AC, et al
    Carotid intima-media thickness and incident hypertension: the Brazilian Longitudinal Study of Adult Health.
    J Hypertens. 2023 Sep 19. doi: 10.1097/HJH.0000000000003567.
    >> Share

  367. OHARA H, Takeuchi F, Kato N, Nabika T, et al
    Genotypes of Stim1 and the proximal region on chromosome 1 exert opposite effects on stroke susceptibility in stroke-prone spontaneously hypertensive rat.
    J Hypertens. 2023 Sep 15. doi: 10.1097/HJH.0000000000003566.
    >> Share

  368. RIVASI G, Ceolin L, Turrin G, Tortu' V, et al
    Prevalence and correlates of frailty in older hypertensive outpatients according to different tools: the HYPER-FRAIL pilot study.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003559.
    >> Share

  369. BOS-ROUBOS AG, Wingbermuhle E, Giesen M, Kersseboom R, et al
    Hypertension with hidden causes: the cognitive and behavioral profile of an adult female with chronic stress and 16p11.2 microdeletion.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003565.
    >> Share

  370. SHI Y, Zhou W
    Threshold effect of systemic immune inflammatory index on hypertension in American adults (NHANES 2017-2020).
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003560.
    >> Share

  371. CHARCHAR FJ, Prestes PR, Mills C, Ching SM, et al
    Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003563.
    >> Share

  372. MA G, Li J, Xie J, Li Y, et al
    Pulse pressure and its association with body composition among Chinese men and women without diagnosed hypertension: the China Kadoorie Biobank.
    J Hypertens. 2023 Sep 7. doi: 10.1097/HJH.0000000000003549.
    >> Share

  373. TROPEA T, Mavichak W, Evangelinos A, Brennan-Richardson C, et al
    Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy.
    J Hypertens. 2023 Sep 1. doi: 10.1097/HJH.0000000000003532.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016